Beta Drugs Ltd. benchmarking: Perfomance to industry peers

Financial

	Beta Drugs	Bliss GVS Pharma	Jagsonpal Pharma
Operational Metrics
Financials
5 yr Average ROE	22.74 %	6.83 %	16.01 %
5yr average Equity Multiplier	1.82	1.3	1.27
5yr Average Asset Turnover Ratio	1.03	0.62	1.09
5yr Avg Net Profit Margin	12.23 %	8.7 %	12.08 %
Price to Book	8.36	1.6	5.53
P/E	38.84	16.5	22.58
5yr Avg Cash Conversion Cycle	7.75 Days	186.56 Days	2.39 Days
Inventory Days	46.07 Days	54.35 Days	37.29 Days
Days Receivable	91.57 Days	189.93 Days	15.63 Days
Days Payable	119.03 Days	75.78 Days	59.94 Days
5yr Average Interest Coverage Ratio	14.42	14.68	66.99
5yr Avg ROCE	27.84 %	13.27 %	18.99 %
5yr Avg Operating Profit Margin	21.76 %	17.03 %	13.23 %
5 yr average Debt to Equity	0.29	0.11	0.01
5yr CAGR Net Profit	29.34 %	4.24 %	26.54 %
5yr Average Return on Assets	12.69 %	5.31 %	12.71 %
Shareholdings
Promoter Holding	66.73 %	35.39 %	67.54 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.02 %	0.84 %	-1.18 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

	Beta Drugs	Bliss GVS Pharma	Jagsonpal Pharma
Product Wise Break-Up	Product Wise Break-Up Oncology 100.0 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 Pharmaceuticals 0	Product Wise Break-Up Anti Malarials 43.0 Anti-fungal 16.0 Oncology 0 Anti Inflammatory 7.0 Pharmaceuticals 0 Antibiotics 5.0 Anti-bacterial 0 Others 29.0	Product Wise Break-Up Antimalarial 0 Anti-fungal, 0 Oncology 0 Anti Inflammatory 0 Pharmaceuticals 100.0 Anti-biotic 0 Anti-bacterial 0
Location Wise Break-Up	Location Wise Break-Up India 71.03 Rest of the World 0 India 0 Others 28.97	Location Wise Break-Up India 6.61 Rest of the World 93.39	Location Wise Break-Up India 0 Rest of the World 0 Others 100